Robert Reiter, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Pfizer
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Lantheus
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Point biopharma
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Oncology)
    Ineligible company: 
    Bayer
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Specialty Not Specified)
    Ineligible company: 
    Genomic Health
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Janssen
  • Attribution: 
    Self
    Type of financial relationship: 
    Investment Interest (Specialty Not Specified)
    Ineligible company: 
    ImaginAb Corporation
Return to Transmisión Web: Avances globales en cáncer de próstata: el rol de las pruebas genéticas y los inhibidores de PARP (2022) - Español